논문KCI 등재
The growing burden of non-alcoholic fatty liver disease on mortality
1
조회
0
다운로드
4
인용
0
참고문헌
키워드
참고문헌 (15)
- 강성희, "KASL clinical practice guidelines: Management of nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 27(3), pp.363~401 (2021), 대한간학회
- Li J, "Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999-2019 : a systematic review and meta-analysis", Lancet Gastroenterol Hepatol, 4, pp.389~398 (2019)
- Younossi ZM, "The global epidemiology of nonalcoholic fatty liver disease(NAFLD)and nonalcoholic steatohepatitis(NASH) : a systematic review", Hepatology (2023)[DOI]
- Michael H. Le, "Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach", Clinical and Molecular Hepatology, 28(4), pp.841~850 (2022), 대한간학회
- Peter Konyn, "Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.43~57 (2023), 대한간학회
- Kim D, "Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States", J Hepatol, 75, pp.1284~1291 (2021)
- Cheng Han Ng, "Nonalcoholic fatty liver disease versus metabolic-associated fatty liver disease: Prevalence, outcomes and implications of a change in name", Clinical and Molecular Hepatology, 28(4), pp.790~801 (2022), 대한간학회
- Younossi ZM, "Are there outcome differences between NAFLD and metabolicassociated fatty liver disease?", Hepatology, 76, pp.1423~1437 (2022)
- de Avila L, "Nonalcoholic fatty liver disease is independently associated with higher all-cause and cause-specific mortality", Clin Gastroenterol Hepatol (2023)[DOI]
- Fu CE, "A metaanalysis on associated risk of mortality in nonalcoholic fatty liver disease", Endocr Pract, 29, pp.33~39 (2023)
- Eunji Ko, "Risk factors in nonalcoholic fatty liver disease", Clinical and Molecular Hepatology, 29, pp.79~85 (2023), 대한간학회
- Kim BK, "Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD", J Hepatol, 77, pp.1482~1490 (2022)
- Chalasani N, "The diagnosis and management of nonalcoholic fatty liver disease : Practice guidance from the American Association for the Study of Liver Diseases", Hepatology, 67, pp.328~357 (2018)
- Younossi ZM, "AGA Clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease : Expert review", Gastroenterology, 160, pp.912~918 (2021)
- Theresa J. Hydes, "Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH", Clinical and Molecular Hepatology, 26(4), pp.383~400 (2020), 대한간학회[DOI]
관련 논문AI추천
Implications of comorbidities in nonalcoholic fatty liver diseaseSherlot Juan Song, Vincent Wai-Sun Wong대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Recent Epidemiology of Nonalcoholic Fatty Liver DiseaseAhmed Aijaz, Kim Donghee, Murag Soumya거트앤리버 소화기연관학회협의회 · Gut and Liver2021 · 제15권 제2호The Impact of Body Composition on the Prognosis of Nonalcoholic Fatty Liver DiseaseLee Ji Yeon거트앤리버 소화기연관학회협의회 · Gut and Liver2024 · 제18권 제4호Non-invasive biomarkers of liver fibrosis in non-alcoholic fatty liver diseaseMaamon Basheer, Mohamed Naffaa, Nimer Assy대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호Causes and risk profiles of mortality among individuals with nonalcoholic fatty liver diseaseAijaz Ahmed, Donghee Kim, Peter Konyn대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Screening strategies for non-alcoholic fatty liver disease: a holistic approach is neededHans-Michael Steffen, Münevver Demir, Philipp Kasper대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제2호
이 간행물의 다른 논문 (53건)
Congratulatory remarksSi Hyun Baepp. 1-1Special thanksSeung Up Kimpp. 4-4MAFLD: How is it different from NAFLD?Ming-Hua Zheng, Jacob George, Cameron Gofton, Yadhavan Upendranpp. 17-31Global incidence and prevalence of nonalcoholic fatty liver diseaseEunice Tan, Mark D. Muthiah, Cheng Han Ng, Margaret LP Teng, Kai En Chan, Darren JH Tan, Wen Hui Lim, Ju Dong Yang, Daniel Q. Huangpp. 32-42Nonalcoholic fatty liver disease and non-liver comorbiditiesRichie Manikat, Mindie H. Nguyenpp. 86-102
